ARTICLE | Clinical News
Coartem artemether/lumefantrine regulatory update
September 22, 2008 7:00 AM UTC
FDA accepted for filing and granted Priority Review to an NDA from Novartis for Coartem artemether/lumefantrine to treat malaria. The company expects a response from FDA in 1Q09. The fixed-dose artemi...